Standout Papers

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer 2005 2026 2012 2019 4.2k
  1. Erlotinib in Previously Treated Non–Small-Cell Lung Cancer (2005)
    Frances A. Shepherd, José Rodrigues Pereira et al. New England Journal of Medicine
  2. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group (2007)
    Malcolm J. Moore, David Goldstein et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 2 from Science/Nature 136 standout
Sub-graph 1 of 13

Citing Papers

Small molecules, big impact: 20 years of targeted therapy in oncology
2020 Standout
Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells
2019 Standout
10 intermediate papers

Works of Daniel de Castro being referenced

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout

Author Peers

Author Last Decade Papers Cites
Daniel de Castro 5940 768 80 4431 1690 26 7.6k
Junming Zhu 4079 923 105 4224 1795 27 7.2k
Renato Martins 4841 362 33 4717 1810 40 6.9k
F. Andrew Dorr 4707 1332 56 2540 1998 47 7.8k
Haiyi Jiang 6737 492 38 8090 2342 52 9.7k
Carlo L. Bello 3020 653 339 3992 3055 52 7.4k
Catherine Delbaldo 6186 1552 61 2673 1736 48 8.0k
В. А. Горбунова 4426 937 58 5438 2215 59 7.0k
Andrea Kay 3189 451 53 4627 3673 45 7.5k
José Rodrigues Pereira 6203 586 37 6929 1967 25 8.6k
David M. Jackman 4838 386 19 5496 2003 87 7.4k

All Works

Loading papers...

Rankless by CCL
2026